Why are most companies failing to benefit from AI? It’s about the people not the tech, says new study
Peer-Reviewed Publication
Updates every hour. Last Updated: 25-Jun-2025 05:10 ET (25-Jun-2025 09:10 GMT/UTC)
Successful uptake of new technology is a matter of emotions — and with 4 in 5 companies saying they’re failing to capitalise on its potential, managers need to know how to deal with them, say researchers from Aalto University.
Summary
- BioChatter is an open-source Python framework for employing large language models (LLMs) in biomedical research.
- BioChatter can support the creation of dedicated LLM-driven solutions for biomedical use cases.
- AI solutions like those built using BioChatter can streamline workflows for non-computational researchers, advancing areas such as personalised medicine and drug discovery.